ST-segment elevation in lead aVR predicts high mortality and severe disease but poorly identifies acute coronary occlusion, redefining it as a marker for high-risk NOMI.
In hemodynamically stable patients, the STE-aVR pattern should be reclassified from a 'STEMI equivalent' requiring immediate catheterization to a marker of high-risk Non-Occlusive Myocardial Infarction (NOMI) to avoid iatrogenic harm.
Absolute Event Rate: 0% vs 0%
The electrocardiographic pattern of ST-segment elevation in lead aVR (STE-aVR) coupled with diffuse ST-segment depression is a finding of profound clinical gravity. Historically termed a “STEMI equivalent” suggestive of acute left main coronary artery occlusion, this designation has driven decades of aggressive reperfusion strategies. However, contemporary angiographic data reveals a stark “Prognostic-Diagnostic Paradox”: while the pattern predicts high mortality and severe anatomical disease, it poorly predicts acute thrombotic occlusion. This monograph provides an exhaustive evaluation of the electrophysiological mechanisms, clinical evidence, and evolving guidelines surrounding lead aVR. Integrating landmark studies from 2013 to 2019 with novel 2025 concepts such as “Northern OMI” and the “Precordial Swirl,” we propose a modernized, physiology-based clinical algorithm. This framework reclassifies the pattern for hemodynamically stable patients from a trigger for immediate catheterization to a marker of high-risk Non-Occlusive Myocardial Infarction (NOMI), necessitating distinct management to avoid iatrogenic harm from mimics while ensuring timely intervention for true ischemia.
Deng et al. (Fri,) reported a other. ST-segment elevation in lead aVR predicts high mortality and severe disease but poorly identifies acute coronary occlusion, redefining it as a marker for high-risk NOMI.